Fairvalue-Calculator Fairvalue-Calculator
EN DE

iXensor Co (6734) Fair Value & Analysis

Healthcare · TW · Market cap 296M TWD

Price7.04 TWD
Fair Value1.67 TWD
Upside-76.3%
Quality95/100
Evidence: Low Range 1.25 TWD – 2.09 TWD

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

iXensor Co (6734) currently trades at 7.04 TWD, while our model-based Fair Value estimate is 1.67 TWD — implying the stock looks roughly 76.3% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

iXensor Co., Ltd. provides technology platform that turns smartphones into medical diagnostic devices through its smart color sensing technology for connected healthcare. It offers PixoTest Vision Analysis System(lipid), and PixoHealth Vision(app) for chronic disease; and Eveline Smart Fertility System and Eveline Care Telehealth Platform for women's health management. The company was founded in 2012 and is based in Taipei, Taiwan.

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -95% Stryker Corporation (S1YK34) -45% Medtronic plc (MDT) -27% Boston Scientific Corporation (B1SX34) -11% Edwards Lifesciences Corporation (EW) -52% Siemens Healthineers AG (SEMHF) +11%

Frequently asked questions

Is iXensor Co (6734) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 1.67 TWD versus a price of 7.04 TWD — about −76% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 6734?
Our 21-model fair value for iXensor Co is 1.67 TWD (as of Jun 24, 2026), built from audited fundamentals. The current price is 7.04 TWD.
What is the quality score of 6734?
iXensor Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.